Serafin Andrew 4
4 · Harmony Biosciences Holdings, Inc. · Filed Jan 28, 2025
Insider Transaction Report
Form 4
Serafin Andrew
CHIEF STRATEGY OFFICER
Transactions
- Tax Payment
Common Stock
2025-01-24$38.01/sh−865$32,879→ 1,635 total - Award
Restricted Stock Units
2025-01-25+10,400→ 10,400 total→ Common Stock (10,400 underlying) - Exercise/Conversion
Common Stock
2025-01-24+2,500→ 2,500 total - Exercise/Conversion
Restricted Stock Units
2025-01-24−2,500→ 7,500 total→ Common Stock (2,500 underlying) - Award
Stock Option
2025-01-25+36,500→ 36,500 totalExercise: $38.01Exp: 2035-01-25→ Common Stock (36,500 underlying)
Footnotes (4)
- [F1]Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.
- [F2]This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.
- [F3]The stock option vests with respect to 25% of the underlying shares on January 25, 2026, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
- [F4]The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.